2020-2025 Global Endometriosis Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)

Endometriosis is a painful disorder in which the layer of tissue that normally surfaces inside the uterus, starts growing outside the uterus. This mainly occurs on the fallopian tubes, ovaries, and tissue around the uterus; however, in exceptional cases it may occur in other parts of the body. The endometriosis leads to various physical symptoms such as severe menstrual cramps, nausea and vomiting, fatigue, diarrhea, constipation, long-term pelvic pain, and periods lasting over 7 days, among others. Moreover, the impending treatment of endometriosis market may lead to infertility, formation of ovarian cysts, inflammation, and scar tissue and adhesion development, among others.
This report elaborates the market size, market characteristics, and market growth of the Endometriosis industry, and breaks down according to the type, application, and consumption area of Endometriosis. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Endometriosis in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Endometriosis market covered in Chapter 13:
Ipsen
Philogen
Valirx
Debiopharm Group
Forendo Pharma
Abbott
Bayer Ag
Orphagen Pharmaceuticals, inc.
Neurocrine Biosciences, Inc.
Allergan
Ogeda S.A.
Teva Pharmaceutical Industries ltd.
Obseva SA
Addex Therapeutics
Elexopharm
Astellas Pharma Inc.
Abbvie Inc.
Takeda Pharmaceutical Company Limited
Kissei Pharmaceutical Co., ltd.
Pfizer, Inc.
Evestra, Inc.
Meditrina Pharmaceuticals
Myovant Sciences ltd.
Astrazeneca
Repros Therapeutics Inc.
Sanofi

In Chapter 6, on the basis of types, the Endometriosis market from 2015 to 2025 is primarily split into:
Ultrasound
Pelvic exam
Laparoscopy
Magnetic Resonance Imaging (MRI)
Hysteroscopy
Sonohysterography

In Chapter 7, on the basis of applications, the Endometriosis market from 2015 to 2025 covers:
Hospitals
Clinics
Research Institutes

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:

Historical Years:

2015-2019

Base Year:

2019

Estimated Year:

2020

Forecast Period:

2020-2025